Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moyle

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
AIDS Reviews|February 11, 2005
Considerations in selecting protease inhibitor therapyBrian A Boyle, Richard A Elion, Graeme J Moyle, et al.
Schizophrenia Bulletin|January 1, 1993
Low-dose depot medication in schizophreniaP L Burnett, C A Galletly, R J Moyle, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 22, 2006
Event-related potentials elicited during a visual Go-Nogo task in adults with phenylketonuriaJ J Moyle, A M Fox, M Bynevelt, et al.
Neuropsychology Review|April 6, 2007
Meta-analysis of neuropsychological symptoms of adolescents and adults with PKUJ J Moyle, A M Fox, M Arthur, et al.
Antiviral Therapy|April 14, 2010
The effect of tenofovir disoproxil fumarate on whole-body insulin sensitivity, lipids and adipokines in healthy volunteersPaul A Randell, Akil G Jackson, Lijie Zhong, et al.
HIV Medicine|May 7, 2005
Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a 24-week randomized trial of treatment simplification using stavudine prolonged-release capsulesS D Portsmouth, J Osorio, K McCormick, et al.
Journal of Clinical and Experimental Neuropsychology|May 15, 2007
A neuropsychological profile of off-diet adults with phenylketonuriaJ J Moyle, A M Fox, M Bynevelt, et al.
AIDS (London, England)|July 20, 2002
Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factorsGraeme J Moyle, Debasis Datta, Sundhiya Mandalia, et al.
AIDS (London, England)|August 16, 2001
Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapyG J Moyle, M Lloyd, B Reynolds, et al.
Journal of Immune Based Therapies and Vaccines|November 4, 2008
Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-upAnna A Herasimtschuk, Samantha J Westrop, Graeme J Moyle, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
AIDS Reviews|February 11, 2005
Considerations in selecting protease inhibitor therapyBrian A Boyle, Richard A Elion, Graeme J Moyle, et al.
Schizophrenia Bulletin|January 1, 1993
Low-dose depot medication in schizophreniaP L Burnett, C A Galletly, R J Moyle, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 22, 2006
Event-related potentials elicited during a visual Go-Nogo task in adults with phenylketonuriaJ J Moyle, A M Fox, M Bynevelt, et al.
Neuropsychology Review|April 6, 2007
Meta-analysis of neuropsychological symptoms of adolescents and adults with PKUJ J Moyle, A M Fox, M Arthur, et al.
Antiviral Therapy|April 14, 2010
The effect of tenofovir disoproxil fumarate on whole-body insulin sensitivity, lipids and adipokines in healthy volunteersPaul A Randell, Akil G Jackson, Lijie Zhong, et al.
HIV Medicine|May 7, 2005
Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a 24-week randomized trial of treatment simplification using stavudine prolonged-release capsulesS D Portsmouth, J Osorio, K McCormick, et al.
Journal of Clinical and Experimental Neuropsychology|May 15, 2007
A neuropsychological profile of off-diet adults with phenylketonuriaJ J Moyle, A M Fox, M Bynevelt, et al.
AIDS (London, England)|July 20, 2002
Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factorsGraeme J Moyle, Debasis Datta, Sundhiya Mandalia, et al.
AIDS (London, England)|August 16, 2001
Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapyG J Moyle, M Lloyd, B Reynolds, et al.
Journal of Immune Based Therapies and Vaccines|November 4, 2008
Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-upAnna A Herasimtschuk, Samantha J Westrop, Graeme J Moyle, et al.
Pageof 8